Galderma Forecast, price target & analysts
Galderma Target price 2026 - Analyst rating & recommendation
Galderma Classifications & Recommendation
Galderma Price Target
| Target Price | CHF204.00 |
| Price | CHF168.15 |
| Potential |
21.32%
register free of charge
|
| Number of Estimates | 19 |
|
19 Analysts have issued a price target Galderma 2027 .
The average Galderma target price is CHF204.00.
This is
21.32%
register free of charge
CHF273.00
62.36%
register free of charge
CHF152.26
9.45%
register free of charge
|
|
| A rating was issued by 23 analysts: 20 Analysts recommend Galderma to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Galderma stock has an average upside potential 2027 of
21.32%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion CHF | 4.35 | 5.41 |
| 18.04% | 24.27% | |
| EBITDA Margin | 17.63% | 25.89% |
| 19.13% | 46.85% |
20 Analysts have issued a sales forecast Galderma 2026 . The average Galderma sales estimate is
This results in the following potential growth metrics:
18 Analysts have issued an Galderma EBITDA forecast 2026. The average Galderma EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | 2.15 | 4.05 |
| 165.43% | 88.37% | |
| P/E | 40.71 | |
| EV/Sales | 7.32 |
20 Analysts have issued a Galderma forecast for earnings per share. The average Galderma EPS is
This results in the following potential growth metrics and future valuations:
Current Galderma Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JEFFERIES |
Locked
➜
Locked
|
Locked | Sep 21 2026 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Sep 21 2026 |
| BNP PARIBAS |
Locked
➜
Locked
|
Locked | Aug 31 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Aug 04 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 08 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 07 2026 |
| H.C. WAINWRIGHT & CO., LLC |
Locked
➜
Locked
|
Locked | Jul 02 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Sep 21 2026 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Sep 21 2026 |
|
Locked
BNP PARIBAS:
Locked
➜
Locked
|
Aug 31 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Aug 04 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 08 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 07 2026 |
|
Locked
H.C. WAINWRIGHT & CO., LLC:
Locked
➜
Locked
|
Jul 02 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
